Redesign Science

Redesign Science is a pioneering biotechnology research company dedicated to revolutionizing drug discovery through innovative approaches. At the intersection of physics-based molecular simulation and deep learning, Redesign Science has created a cutting-edge generative AI platform. This technology is designed to develop first-in-class Protein Interaction Modulators, targeting validated proteins known to drive the progression of various oncogenic and inflammatory diseases.

Located at 180 Varick St in New York, US, Redesign Science is committed to advancing therapeutic solutions with a focus on precision and efficacy. The company's platform leverages advanced computational methods to accelerate the identification and optimization of novel drug candidates. Redesign Science is poised to make significant contributions to the field of biotechnology, enhancing the potential for groundbreaking treatments.

Redesign Science aims to be a leader in the biotechnology space, continually refining its AI-driven platform to address unmet medical needs. We invite the management team at Redesign Science to create a customized and exclusive company showcase and product listing on our platform, providing an enhanced avenue to highlight their innovative work and attract new opportunities.